Volume 10, Number 1—January 2004
Research
Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from Pigs to Humans, Taiwan
Po-Ren Hsueh*†
, Lee-Jene Teng*†, Sung-Pin Tseng*, Chao-Fu Chang‡, Jen-Hsien Wan†, Jing-Jou Yan†, Chun-Ming Lee†, Yin-Ching Chuang†, Wen-Kuei Huang†, Dine Yang†, Jainn-Ming Shyr†, Kwok-Woon Yu†, Li-Shin Wang†, Jang-Jih Lu†, Wen-Chien Ko†, Jiunn-Jong Wu†, Feng-Yee Chang†, Yi-Chueh Yang†, Yeu-Jun Lau†, Yung-Ching Liu†, Cheng-Yi Liu†, Shen-Wu Ho†, and Kwen-Tay Luh*†
, Lee-Jene Teng*†, Sung-Pin Tseng*, Chao-Fu Chang‡, Jen-Hsien Wan†, Jing-Jou Yan†, Chun-Ming Lee†, Yin-Ching Chuang†, Wen-Kuei Huang†, Dine Yang†, Jainn-Ming Shyr†, Kwok-Woon Yu†, Li-Shin Wang†, Jang-Jih Lu†, Wen-Chien Ko†, Jiunn-Jong Wu†, Feng-Yee Chang†, Yi-Chueh Yang†, Yeu-Jun Lau†, Yung-Ching Liu†, Cheng-Yi Liu†, Shen-Wu Ho†, and Kwen-Tay Luh*†
Figure 3
Figure 3. Accumulation of ciprofloxacin by the two ciprofloxacin-resistant isolates of genosubtype Ia of Salmonella enterica serotype Typhimurium and genosubtype B1 of S. enterica serotype Choleraesuis and one clinical isolate of S. enterica serotype Typhimurium (ciprofloxacin MIC = 0.06 μg/mL). Carbonyl cyanide m-chlorophenylhydrazone (CCCP) (100 μM) was added at the time indicated by the arrow.
Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.